Madison Elizabeth Amos, PA-C

Madison Amos practices at Greenbrae Dermatology, a Medical Corporation in Greenbrae, California.

Madison Amos' NPI, 1477067239, was assigned on November 30, 2017. Madison Amos holds Connecticut license 5030.

Madison Amos' primary practice is Greenbrae Dermatology, a Medical Corporation, at 501 Sir Francis Drake Blvd, Greenbrae, CA 94904 in Marin County. The practice phone is (415) 925-0550.

Madison Amos' primary practice is Greenbrae Dermatology, a Medical Corporation in Greenbrae, California. The medical group on file is Greenbrae Dermatology. Dmand AI also links Madison Amos to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Madison Amos practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical is Madison Amos' primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Dmand AI has Madison Amos' licenses on file in 3 states: Connecticut, California and Colorado.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes and psoriasis among the conditions Madison Amos treats.

CMS data shows 1,215 Medicare services from Madison Amos across 11 procedure codes in 2024, for 297 Medicare patients. Medicare paid $59,763 for them. Every service was in an office.

CMS counts 297 Medicare patients who saw Madison Amos in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high cholesterol, and 53% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Madison Amos' median patient age at 56, with 59% women.

In 2024, Madison Amos wrote 298 Medicare Part D claims for 156 patients. 95% of them were for generic drugs. CMS names the drug for 222 of them, across 7 drugs with 11 or more claims each, at $4,235 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Madison Amos for performance year 2024, reported as part of a group. Madison Amos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Madison Amos from 15 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $138.